129 related articles for article (PubMed ID: 20515768)
1. Add-on blockade of (pro)renin receptor in imidapril-treated diabetic SHRsp.
Seki Y; Ichihara A; Mizuguchi Y; Sakoda M; Kurauchi-Mito A; Narita T; Kinouchi K; Bokuda K; Itoh H
Front Biosci (Elite Ed); 2010 Jun; 2(3):972-9. PubMed ID: 20515768
[TBL] [Abstract][Full Text] [Related]
2. Improvement of organ damage by a non-depressor dose of imidapril in diabetic spontaneously hypertensive rats.
Tomita N; Yamasaki K; Izawa K; Kunugiza Y; Osako MK; Ogihara T; Morishita R
Int J Mol Med; 2007 Apr; 19(4):571-9. PubMed ID: 17334632
[TBL] [Abstract][Full Text] [Related]
3. Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats.
te Riet L; van den Heuvel M; Peutz-Kootstra CJ; van Esch JH; van Veghel R; Garrelds IM; Musterd-Bhaggoe U; Bouhuizen AM; Leijten FP; Danser AH; Batenburg WW
Am J Physiol Renal Physiol; 2014 May; 306(10):F1179-89. PubMed ID: 24694588
[TBL] [Abstract][Full Text] [Related]
4. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.
Feldman DL; Jin L; Xuan H; Contrepas A; Zhou Y; Webb RL; Mueller DN; Feldt S; Cumin F; Maniara W; Persohn E; Schuetz H; Jan Danser AH; Nguyen G
Hypertension; 2008 Jul; 52(1):130-6. PubMed ID: 18490518
[TBL] [Abstract][Full Text] [Related]
5. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
[TBL] [Abstract][Full Text] [Related]
6. (Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats.
Muller DN; Klanke B; Feldt S; Cordasic N; Hartner A; Schmieder RE; Luft FC; Hilgers KF
Hypertension; 2008 Mar; 51(3):676-81. PubMed ID: 18212268
[TBL] [Abstract][Full Text] [Related]
7. The (pro)renin receptor blocker handle region peptide upregulates endothelium-derived contractile factors in aliskiren-treated diabetic transgenic (mREN2)27 rats.
Batenburg WW; van den Heuvel M; van Esch JH; van Veghel R; Garrelds IM; Leijten F; Danser AH
J Hypertens; 2013 Feb; 31(2):292-302. PubMed ID: 23303354
[TBL] [Abstract][Full Text] [Related]
8. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension.
Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M; Suzuki F; Nakagawa T; Nishiyama A; Inagami T; Hayashi M
Hypertension; 2006 May; 47(5):894-900. PubMed ID: 16585419
[TBL] [Abstract][Full Text] [Related]
9. Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.
Huang J; Matavelli LC; Siragy HM
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):215-21. PubMed ID: 21265872
[TBL] [Abstract][Full Text] [Related]
10. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade.
Takahashi H; Ichihara A; Kaneshiro Y; Inomata K; Sakoda M; Takemitsu T; Nishiyama A; Itoh H
J Am Soc Nephrol; 2007 Jul; 18(7):2054-61. PubMed ID: 17538189
[TBL] [Abstract][Full Text] [Related]
11. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
Ichihara A; Suzuki F; Nakagawa T; Kaneshiro Y; Takemitsu T; Sakoda M; Nabi AH; Nishiyama A; Sugaya T; Hayashi M; Inagami T
J Am Soc Nephrol; 2006 Jul; 17(7):1950-61. PubMed ID: 16738017
[TBL] [Abstract][Full Text] [Related]
12. High salt intake damages the heart through activation of cardiac (pro) renin receptors even at an early stage of hypertension.
Hayakawa Y; Aoyama T; Yokoyama C; Okamoto C; Komaki H; Minatoguchi S; Iwasa M; Yamada Y; Kawamura I; Kawasaki M; Nishigaki K; Mikami A; Suzuki F; Minatoguchi S
PLoS One; 2015; 10(3):e0120453. PubMed ID: 25799069
[TBL] [Abstract][Full Text] [Related]
13. Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats.
van Esch JH; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
Hypertension; 2011 Apr; 57(4):852-8. PubMed ID: 21321303
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression.
He M; Zhang L; Shao Y; Xue H; Zhou L; Wang XF; Yu C; Yao T; Lu LM
Mol Cell Endocrinol; 2010 Feb; 315(1-2):188-94. PubMed ID: 19879325
[TBL] [Abstract][Full Text] [Related]
15. Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor.
Thomas CM; Yong QC; Seqqat R; Chandel N; Feldman DL; Baker KM; Kumar R
Clin Sci (Lond); 2013 Apr; 124(8):529-41. PubMed ID: 23116220
[TBL] [Abstract][Full Text] [Related]
16. Possible contribution of the non-proteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats.
Nagai Y; Ichihara A; Nakano D; Kimura S; Pelisch N; Fujisawa Y; Hitomi H; Hosomi N; Kiyomoto H; Kohno M; Ito H; Nishiyama A
Exp Physiol; 2009 Sep; 94(9):1016-23. PubMed ID: 19502292
[TBL] [Abstract][Full Text] [Related]
17. Diverse effects of long-term treatment with imidapril and irbesartan on cell growth signal, apoptosis and collagen type I expression in the left ventricle of spontaneously hypertensive rats.
Wang JM; Wang Y; Zhu ZS; Zhang MC; Zou Y; Li JJ; Li MJ; Jiang XJ; Li XY
Life Sci; 2004 Jun; 75(4):407-20. PubMed ID: 15147828
[TBL] [Abstract][Full Text] [Related]
18. Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
Malfitano C; De Angelis K; Fernandes T; Wichi RB; Rosa K; Pazzine M; Mostarda C; Ronchi FA; Oliveira EM; Casarini DE; Irigoyen MC
J Cardiovasc Pharmacol; 2012 Jan; 59(1):58-65. PubMed ID: 21921804
[TBL] [Abstract][Full Text] [Related]
19. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
[TBL] [Abstract][Full Text] [Related]
20. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
